PositiveID Reports 2015 Revenue of $2.9 Million, Up 211% Year over Year
12 avr. 2016 08h30 HE
|
PositiveID Corporation
DELRAY BEACH, Fla., April 12, 2016 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a life sciences company focused on detection and diagnostics, announced its...
PositiveID Enters Into Strategic Financing for $2.4 Million
17 août 2015 08h30 HE
|
PositiveID Corporation
Fixed-Price Financing Struck at a Premium to Market Proceeds to Be Used to Develop Field-Testable Units of PositiveID’s Firefly Dx Pathogen Detection System for Point-Of-Need Diagnostics DELRAY...
PositiveID Corporation Announces License of iglucose Technology for Up to $2 Million
20 févr. 2013 08h30 HE
|
PositiveID Corporation
DELRAY BEACH, Fla., Feb. 20, 2013 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCQB:PSID), a developer of biological detection and diagnostics solutions, today announced it...
PositiveID Corporation Awarded U.S. Patent No. 8,133,451 for First-of-Its-Kind Detection System for Molecular Biological Diagnostics
20 mars 2012 08h30 HE
|
PositiveID Corporation
DELRAY BEACH, Fla., March 20, 2012 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID") (OTCBB:PSID), an emerging growth company and developer of advanced technologies for diabetes management as...
PositiveID Corporation Receives an Additional Key Patent for Fieldable Biological Detection
02 août 2011 16h30 HE
|
PositiveID Corporation
DELRAY BEACH, Fla., Aug. 2, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (Nasdaq:PSID), a developer of medical technologies for diabetes management, clinical diagnostics...
PositiveID Corporation Awarded Key Patent for Sample Prep of DNA and RNA
20 juil. 2011 08h30 HE
|
PositiveID Corporation
Intellectual Property to Support Sales and Licensing of Diagnostic Products
Sample Prep Technology Can be Used in the Field or Clinical Environment to Quickly Obtain and Purify Samples for...